In contrast, administration of the RPS6KA2 overexpression plasmid together with cisplatin reduced the expression of ATG5, ATG7, and BECN1 and inhibited tumor expansion (Fig. 8B). This evidence concerns the gene RPS6KA2 and neoplasm.